Chargement en cours...
Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations
OBJECTIVE: To evaluate the benefit–risk profile (BRP) of oxycodone/naloxone (OXN) and tapentadol (TAP) in patients with chronic low back pain (cLBP) with a neuropathic component (NC) in routine clinical practice. METHODS: This was a blinded end point analysis of randomly selected 12-week routine/ope...
Enregistré dans:
| Publié dans: | J Pain Res |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5115682/ https://ncbi.nlm.nih.gov/pubmed/27881925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S112418 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|